Yueyin Venture Capital

Yueyin Venture Capital is an investment institution specializing in the healthcare sector. It aims to enhance patient care by focusing on medical services across three key dimensions: disease types, emerging technologies, and the industrial chain related to medical services. The firm invests in various fields, including medical devices, biomedicine, in vitro diagnostics, and smart medical solutions. Established by professionals from both the medical and investment sectors, Yueyin Venture Capital is committed to fostering the growth and innovation of the domestic medical and health industry in China.

You Linlin

Executive Director

14 past transactions

Hygea Medical

Series D in 2023
Hygea Medical Technology Co. Ltd. is a Beijing-based company specializing in the design and manufacture of medical devices aimed at oncology treatments. The company develops anti-tumor treatment equipment, including cryosurgery and cryopreservation devices. Hygea's solutions are specifically tailored to address various cancers, including those affecting the lung, liver, breast, and kidney. The company is committed to advancing its micro-invasive technologies and Cryo-HITTM technology to enhance treatment efficiency for patients with tumor diseases. Through its innovative approach, Hygea Medical aims to improve the effectiveness of cancer therapies.

Tsingke Biotech

Series A in 2022
Tsingke Biotechnology focuses on the research and development of synthetic genomics and biosynthetic products. The company's operations are organized into three primary areas: the provision of synthetic genomics products and services, the supply of life science research equipment and raw materials, and biomanufacturing contract research organization and contract development and manufacturing services. Through these avenues, Tsingke Biotechnology aims to advance the field of biotechnology and support life sciences research and development.

Kossel Medical

Venture Round in 2022
Kossel Medical specializes in the research and development of vascular interventional medical devices. The company manufactures a range of products, including coronary stent systems, PTA balloon catheters, and electrophysiology devices. By focusing on these areas, Kossel Medical aims to enhance clinical treatment options for patients, providing innovative solutions in the field of interventional cardiology and vascular care.

GX Pharma

Venture Round in 2020
GX Pharma is a contract research organization (CRO) that specializes in drug research and development as well as clinical research services. The company offers comprehensive solutions for the registration and declaration of novel drugs, biological products, and medical devices. By streamlining the clinical research process, GX Pharma helps clients expedite product listing cycles and enhance market entry efficiency. Since 2018, the company has been recognized as one of the "Top 20 Outsourcing Companies in China's Pharmaceutical Industry," reflecting its commitment to quality and innovation in the pharmaceutical sector.

TCR Cure

Series B in 2019
Chongqing TCRCure Biotechnology Co., Ltd. is a Beijing-based company that specializes in the research, development, and industrialization of tumor immune cell therapies. The firm offers a range of products and services, including universal T cell receptor chimeric T cell therapy, individualized TCR tumor immune cell customization therapy, and CAR-T therapy. Additionally, TCRCure is involved in clinical immune monitoring and immunological efficacy assessment, as well as providing virus and carrier production for external technical services. The company emphasizes a streamlined approach to biotechnology development, focusing on high throughput antigen-specific TCR cloning, industry-scale virus production, T cell genetic engineering, and immune cell manufacturing.

Hanyu Medical

Series B in 2018
Hanyu Medical is a pioneering company in the development, production, and sale of transcatheter mitral valve repair devices. Specializing in minimally invasive treatments for mitral valve regurgitation, the company’s flagship product is the Valve Clamp, an interventional device designed to assist in the closure of heart valves during surgical procedures. By focusing on innovative solutions for heart valve diseases, Hanyu Medical aims to enhance surgical outcomes and patient recovery through its advanced medical technologies.

Yidianling

Series A in 2018
Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.

Yidianling

Series A in 2018
Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.

Rivamed

Series A in 2018
Rivamed is a provider of logistics management systems and medical material management solutions tailored for the healthcare sector. Utilizing Hospital Internet of Things (HIoT) technology, the company integrates medical resources to enhance operational efficiency and reduce errors within medical environments. Rivamed's offerings include intelligent storage solutions, medical devices, printers, and drug management cabinets, all designed to support closed-loop management of medical resources. Through independent innovation, the company aims to deliver advanced management concepts that streamline healthcare operations and improve the overall effectiveness of medical staff.

Campo Imaging

Series A in 2017
Campo Imaging is a Chinese company specializing in medical imaging technology and services. Founded in 2010, the company develops and manufactures medical imaging equipment and operates diagnostic centers that provide a range of services, including CT scans, magnetic resonance imaging, digital radiography, ultrasounds, dynamic electrocardiograms, tele-consultation, and consultations for complex cases. By focusing on innovative imaging solutions, Campo Imaging aims to enhance patient care and streamline the medical imaging process, facilitating healthier lives for its clients. The company is headquartered in China.

GenomePrecision

Series A in 2017
Beijing GenomePrecision Technology Co., Ltd. is a molecular diagnostic company focused on developing precision medicine tests to enhance the diagnosis and treatment of various diseases, including blood tumors, transplantation needs, and cardiovascular conditions. Established in 2015 and headquartered in Beijing, the company integrates research and development, manufacturing, distribution, and registration of its products. GenomePrecision utilizes advanced molecular technology platforms, such as real-time fluorescence quantitative PCR, Sanger sequencing, high-throughput next-generation sequencing, and capillary electrophoresis, to create a diverse range of diagnostic products. These include tests for leukemia, lymphoma, solid tumors, and pharmacogenomics, as well as tools for organ transplant monitoring and pathogen detection. The company also produces molecular diagnostic kits for targeted drug testing and auxiliary diagnosis of cervical cancer, among other applications. By focusing on clinical diagnosis and treatment requirements, GenomePrecision aims to improve patient outcomes through innovative molecular diagnostics.

Mingyizhudao

Series B in 2016
mingyizhudao is the leading Internet + surgery platform and the only medical case sharing economic case research base in China. Its gold medal product “Medical Doctor” was launched in March 2015. It has become the authoritative Internet medical surgery platform in China. It has signed more than 40,000 experts from the top director level of the top three hospitals at home and abroad, and 100,000 grassroots doctors, over 1,000. Home-based cooperative hospital.

InVision

Angel Round in 2016
Shanghai Invision Health Technology Company Limited is a digital technology agency focused on the medical industry. Established in 2013 and based in Shanghai, China, the company integrates advanced digital technologies with industry-specific knowledge to enhance communication and information dissemination in healthcare. Invision specializes in developing medical mobile applications, producing 3D medical visuals, and creating digital display solutions. Its innovative use of virtual reality technology aims to streamline the communication of medical information, thereby improving engagement and understanding within the medical community.

CN-Healthcare

Series B in 2016
CN-Healthcare provides online health data and aims to integrate updates and data about the healthcare business. In order to provide customers with access to current healthcare information and increase public understanding of the health industry, the platform focuses on providing medical resource integration services. The products offered by the platform include health industry websites, mobile newspapers, and mobile medical applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.